This study was designed to evaluate the efficacy of continuous hepatic artery infusion chemotherapy and chemoembolization for the treatment of liver metastases from colorectal cancer.
本文将动脉介入与持续灌注化疗药物两种方法相结合，观察结直肠癌肝转移患者经肝动脉介入栓塞或持续灌注化疗的临床疗效。
Conclusions the local infusion chemotherapy via hepatic artery and portal vein was an effective therapy for those who could not undergo the resection of advanced liver cancer.
结论肝动脉局部灌注化疗对不能手术切除的晚期肝癌，作为治疗手段不失为一种有效的方法。
Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
Conclusions: Kanglaite injection combined with chemical medicine through artery infusion has relatively better curative effects on hepatic metastasis carcinoma.
结论：康莱特联合化学药物动脉灌注治疗转移性肝癌有较好的疗效。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
Our present date showed the treatment of HCCs with SDSR plus hepatic artery embolization and infusion has an exact curative effect.
充分显示出立体 定向适形放疗联合肝动脉灌注对中晚期肝癌的良好效果。
Our present date showed the treatment of HCCs with SDSR plus hepatic artery embolization and infusion has an exact curative effect.
充分显示出立体 定向适形放疗联合肝动脉灌注对中晚期肝癌的良好效果。
应用推荐